Advancements in Physiotherapy

\r\n There has been renewed interest in the spondyloarthropathy family of chronic inflammatory Pain medication conditions, which has been fuelled to a large extent by the biologic era. Over the period of the past 2 years, there have been several notable advances. First, there have been several large, high-quality randomized controlled trials evaluating the tumour necrosis factor (TNF) blockers and conservative treatments such as physiotherapy and non-steroidal anti-inflammatory drugs for use in spondyloarthropathy. Operant behavioural and cognitive-behavioural treatment for chronic low back pain

\r\n

\r\n

    Related Conference of Advancements in Physiotherapy

    Advancements in Physiotherapy Conference Speakers